Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Everything to know about HIV treatment PrEP, including what is PrEP, PrEP side effects, ... (pre-exposure prophylaxis), a prescribed medication that lowers your chance of getting the virus.

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

December 21, 2021 FDA approves Apretude, first injectable PrEP treatment to lower risk of HIV The drug only needs to be given once every two months, which experts say could improve usage ...

SAN FRANCISCO, Nov. 30, 2017 /PRNewswire/ -- PlushCare, the direct-to-consumer online urgent care provider, today announced the launch and availability of PrEP (pre-exposure prophylaxis) therapy ...

Researchers called the treatment “pre-exposure prophylaxis,” or PrEP for short. Others have called it “the new condom. ...

Lenacapavir received approval from the U.S. Food and Drug Administration (FDA) in June 2025 and has subsequently been endorsed in the updated World Health Organisation (WHO) guidelines on long-acting ...

Self-perceived HIV risk, learning about pre-exposure prophylaxis (PrEP) via trusted sources, positive healthcare experiences and health insurance coverage are facilitators of PrEP initiation and ...

Early antiretroviral treatment and pre-exposure prophylaxis, or PrEP " two elements of San Francisco's Getting to Zero initiative " are keys to reigning in the HIV epidemic worldwide, and the city is ...

A study that compared pre-exposure prophylaxis (PrEP) usage rates in 19 US cities with the rates of HIV diagnosis has found that the cities with the highest rates of PrEP use in at-risk people had ...

The PrEP treatment involved a pill containing a combination of two anti-HIV drugs, emtricitabine and tenofovir, taken daily or around the time of sexual activity.